

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.66147371 |
| 2 | synaptic vesicle exocytosis (GO:0016079) | 6.44208601 |
| 3 | * synaptic vesicle docking involved in exocytosis (GO:0016081) | 6.35090456 |
| 4 | synaptic vesicle maturation (GO:0016188) | 6.24289809 |
| 5 | * glutamate secretion (GO:0014047) | 6.22487684 |
| 6 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 6.21990382 |
| 7 | regulation of synaptic vesicle exocytosis (GO:2000300) | 6.13710612 |
| 8 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 6.11124545 |
| 9 | vocalization behavior (GO:0071625) | 5.98573894 |
| 10 | protein localization to synapse (GO:0035418) | 5.55466150 |
| 11 | locomotory exploration behavior (GO:0035641) | 5.52243647 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.47969461 |
| 13 | neuron cell-cell adhesion (GO:0007158) | 5.32240302 |
| 14 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.29583651 |
| 15 | regulation of synaptic vesicle transport (GO:1902803) | 5.28505327 |
| 16 | neurotransmitter-gated ion channel clustering (GO:0072578) | 5.26055348 |
| 17 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 5.12546812 |
| 18 | postsynaptic membrane organization (GO:0001941) | 4.70807628 |
| 19 | presynaptic membrane assembly (GO:0097105) | 4.60264998 |
| 20 | sodium ion export (GO:0071436) | 4.58921588 |
| 21 | * neurotransmitter secretion (GO:0007269) | 4.49725213 |
| 22 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.47408076 |
| 23 | positive regulation of synapse maturation (GO:0090129) | 4.41680959 |
| 24 | neuronal action potential propagation (GO:0019227) | 4.36767495 |
| 25 | exploration behavior (GO:0035640) | 4.34574375 |
| 26 | synaptic transmission, glutamatergic (GO:0035249) | 4.32210134 |
| 27 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.31784079 |
| 28 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.24744292 |
| 29 | presynaptic membrane organization (GO:0097090) | 4.22027424 |
| 30 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.16399053 |
| 31 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.13313643 |
| 32 | positive regulation of membrane potential (GO:0045838) | 4.12432589 |
| 33 | neuron-neuron synaptic transmission (GO:0007270) | 4.08688901 |
| 34 | positive regulation of dendritic spine development (GO:0060999) | 4.04640604 |
| 35 | layer formation in cerebral cortex (GO:0021819) | 4.04335940 |
| 36 | proline transport (GO:0015824) | 4.02383579 |
| 37 | neuronal ion channel clustering (GO:0045161) | 4.01296881 |
| 38 | L-amino acid import (GO:0043092) | 4.00301488 |
| 39 | regulation of postsynaptic membrane potential (GO:0060078) | 3.96812894 |
| 40 | regulation of synapse structural plasticity (GO:0051823) | 3.94057157 |
| 41 | regulation of synaptic plasticity (GO:0048167) | 3.90349336 |
| 42 | * regulation of neurotransmitter secretion (GO:0046928) | 3.89662707 |
| 43 | glutamate receptor signaling pathway (GO:0007215) | 3.89602437 |
| 44 | long-term synaptic potentiation (GO:0060291) | 3.89500344 |
| 45 | regulation of ARF protein signal transduction (GO:0032012) | 3.78401160 |
| 46 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.76357073 |
| 47 | auditory behavior (GO:0031223) | 3.76013055 |
| 48 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.75457674 |
| 49 | dendritic spine morphogenesis (GO:0060997) | 3.74820183 |
| 50 | amino acid import (GO:0043090) | 3.73749136 |
| 51 | cerebellar granule cell differentiation (GO:0021707) | 3.73714217 |
| 52 | activation of protein kinase A activity (GO:0034199) | 3.69812297 |
| 53 | synaptic vesicle endocytosis (GO:0048488) | 3.69263461 |
| 54 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.67193833 |
| 55 | mechanosensory behavior (GO:0007638) | 3.58599302 |
| 56 | long-term memory (GO:0007616) | 3.56216393 |
| 57 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.56167185 |
| 58 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.55637241 |
| 59 | neuron recognition (GO:0008038) | 3.55137268 |
| 60 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.53454358 |
| 61 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.51590308 |
| 62 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.50834540 |
| 63 | * neurotransmitter transport (GO:0006836) | 3.50779078 |
| 64 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.50742026 |
| 65 | potassium ion homeostasis (GO:0055075) | 3.48746897 |
| 66 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.48323715 |
| 67 | regulation of synapse maturation (GO:0090128) | 3.46937419 |
| 68 | * regulation of neurotransmitter transport (GO:0051588) | 3.44650897 |
| 69 | axonal fasciculation (GO:0007413) | 3.41648159 |
| 70 | chemosensory behavior (GO:0007635) | 3.40169609 |
| 71 | response to histamine (GO:0034776) | 3.39801977 |
| 72 | detection of calcium ion (GO:0005513) | 3.37961261 |
| 73 | regulation of vesicle fusion (GO:0031338) | 3.36317501 |
| 74 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.32122480 |
| 75 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.29186337 |
| 76 | regulation of dendritic spine development (GO:0060998) | 3.26178423 |
| 77 | * positive regulation of neurotransmitter secretion (GO:0001956) | 3.26159797 |
| 78 | neuromuscular process controlling posture (GO:0050884) | 3.24029989 |
| 79 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.23117218 |
| 80 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.21844163 |
| 81 | response to auditory stimulus (GO:0010996) | 3.21492420 |
| 82 | membrane depolarization (GO:0051899) | 3.20473233 |
| 83 | * regulation of neurotransmitter levels (GO:0001505) | 3.17986419 |
| 84 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.17588950 |
| 85 | gamma-aminobutyric acid transport (GO:0015812) | 3.15804017 |
| 86 | regulation of glutamate secretion (GO:0014048) | 3.15269870 |
| 87 | * positive regulation of synaptic transmission (GO:0050806) | 3.14412112 |
| 88 | * regulation of synaptic transmission (GO:0050804) | 3.12377700 |
| 89 | behavioral response to cocaine (GO:0048148) | 3.09765657 |
| 90 | potassium ion import (GO:0010107) | 3.09048932 |
| 91 | cell communication by electrical coupling (GO:0010644) | 3.08891452 |
| 92 | neuromuscular synaptic transmission (GO:0007274) | 3.07396238 |
| 93 | neuromuscular process controlling balance (GO:0050885) | 3.07033532 |
| 94 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.06367534 |
| 95 | synaptic vesicle transport (GO:0048489) | 3.06196361 |
| 96 | establishment of synaptic vesicle localization (GO:0097480) | 3.06196361 |
| 97 | acidic amino acid transport (GO:0015800) | 3.05273418 |
| 98 | * positive regulation of neurotransmitter transport (GO:0051590) | 3.04746166 |
| 99 | cerebellar Purkinje cell layer development (GO:0021680) | 3.03444360 |
| 100 | learning (GO:0007612) | 3.01635897 |
| 101 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.01141667 |
| 102 | * synaptic transmission (GO:0007268) | 3.00653384 |
| 103 | * regulation of exocytosis (GO:0017157) | 3.00540349 |
| 104 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.99381674 |
| 105 | synapse assembly (GO:0007416) | 2.98916284 |
| 106 | * vesicle docking involved in exocytosis (GO:0006904) | 2.98271920 |
| 107 | cell migration in hindbrain (GO:0021535) | 2.98237464 |
| 108 | positive regulation of dendrite development (GO:1900006) | 2.97916373 |
| 109 | dendrite morphogenesis (GO:0048813) | 2.97428779 |
| 110 | * signal release (GO:0023061) | 2.97307494 |
| 111 | regulation of female receptivity (GO:0045924) | 2.96247835 |
| 112 | axon ensheathment in central nervous system (GO:0032291) | 2.95909278 |
| 113 | central nervous system myelination (GO:0022010) | 2.95909278 |
| 114 | negative regulation of dendrite development (GO:2000171) | 2.94957126 |
| 115 | cellular potassium ion homeostasis (GO:0030007) | 2.93774313 |
| 116 | negative regulation of microtubule polymerization (GO:0031115) | 2.92691073 |
| 117 | membrane hyperpolarization (GO:0060081) | 2.92449090 |
| 118 | innervation (GO:0060384) | 2.91803137 |
| 119 | transferrin transport (GO:0033572) | 2.90318524 |
| 120 | membrane depolarization during action potential (GO:0086010) | 2.89902350 |
| 121 | positive regulation of synapse assembly (GO:0051965) | 2.89606764 |
| 122 | phosphorelay signal transduction system (GO:0000160) | 2.89408218 |
| 123 | dendritic spine organization (GO:0097061) | 2.88360102 |
| 124 | mating behavior (GO:0007617) | 2.87857447 |
| 125 | negative regulation of amino acid transport (GO:0051956) | 2.87691181 |
| 126 | neuromuscular process (GO:0050905) | 2.86446398 |
| 127 | regulation of dendrite morphogenesis (GO:0048814) | 2.85235601 |
| 128 | intraspecies interaction between organisms (GO:0051703) | 2.85089612 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.98851301 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.03144046 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.23417271 |
| 4 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.14165952 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.03705736 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.00514229 |
| 7 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.94766458 |
| 8 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.77747507 |
| 9 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.75549206 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.70452663 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.70452663 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.62830511 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.59773316 |
| 14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.55934853 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.55523318 |
| 16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.52646922 |
| 17 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.48169295 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.47602600 |
| 19 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.46182642 |
| 20 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.45549986 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.28958199 |
| 22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.26423374 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.17276679 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.16928091 |
| 25 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.16228404 |
| 26 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.09753406 |
| 27 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.07404531 |
| 28 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.05864255 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.05173722 |
| 30 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.03336907 |
| 31 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.99926084 |
| 32 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.87000801 |
| 33 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.84807268 |
| 34 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.77298065 |
| 35 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.68584708 |
| 36 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.68443894 |
| 37 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.68288622 |
| 38 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.65561301 |
| 39 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.53661513 |
| 40 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.52186456 |
| 41 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.51787154 |
| 42 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.50383808 |
| 43 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.49351292 |
| 44 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.46773263 |
| 45 | P300_19829295_ChIP-Seq_ESCs_Human | 1.43293644 |
| 46 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.40165564 |
| 47 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.39271285 |
| 48 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.38872165 |
| 49 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.38851888 |
| 50 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.38177497 |
| 51 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.35666756 |
| 52 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.32363246 |
| 53 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.32279895 |
| 54 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.30005892 |
| 55 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.29659912 |
| 56 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.27912774 |
| 57 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.27537864 |
| 58 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.26748560 |
| 59 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.26464710 |
| 60 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.25832844 |
| 61 | AR_25329375_ChIP-Seq_VCAP_Human | 1.25354037 |
| 62 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.25042315 |
| 63 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.24900327 |
| 64 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.23220108 |
| 65 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.21949014 |
| 66 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.21709297 |
| 67 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.21239206 |
| 68 | AR_19668381_ChIP-Seq_PC3_Human | 1.17671301 |
| 69 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.17338578 |
| 70 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.17054125 |
| 71 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16318696 |
| 72 | STAT3_23295773_ChIP-Seq_U87_Human | 1.16009626 |
| 73 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.14540724 |
| 74 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.13829007 |
| 75 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12659600 |
| 76 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.11926456 |
| 77 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.11350822 |
| 78 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.10777898 |
| 79 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.09201105 |
| 80 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.09056026 |
| 81 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.08602395 |
| 82 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.08596791 |
| 83 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.07170055 |
| 84 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.06908912 |
| 85 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.06697032 |
| 86 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.06395320 |
| 87 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.05097972 |
| 88 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04819047 |
| 89 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.03583305 |
| 90 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.03433771 |
| 91 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02655325 |
| 92 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.02601088 |
| 93 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.02446105 |
| 94 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.02412833 |
| 95 | FUS_26573619_Chip-Seq_HEK293_Human | 1.02381067 |
| 96 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.01982431 |
| 97 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.01776465 |
| 98 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.00914857 |
| 99 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.00282405 |
| 100 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00236166 |
| 101 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.00095691 |
| 102 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.99924281 |
| 103 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.99855018 |
| 104 | * P68_20966046_ChIP-Seq_HELA_Human | 0.99789427 |
| 105 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.98960016 |
| 106 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98870197 |
| 107 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.97649366 |
| 108 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.96503762 |
| 109 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96197265 |
| 110 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.96045279 |
| 111 | KDM2B_26808549_Chip-Seq_K562_Human | 0.96014957 |
| 112 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95145818 |
| 113 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.94470110 |
| 114 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94470110 |
| 115 | JUN_21703547_ChIP-Seq_K562_Human | 0.92686297 |
| 116 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.92458938 |
| 117 | RXR_22108803_ChIP-Seq_LS180_Human | 0.91270982 |
| 118 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.90714307 |
| 119 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.90167462 |
| 120 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.89912756 |
| 121 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.89509342 |
| 122 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.89493119 |
| 123 | VDR_22108803_ChIP-Seq_LS180_Human | 0.89477309 |
| 124 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.89086343 |
| 125 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.87999997 |
| 126 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.87234893 |
| 127 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86365299 |
| 128 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86044551 |
| 129 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.85599100 |
| 130 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.84236012 |
| 131 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.83929918 |
| 132 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.83756716 |
| 133 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.83689056 |
| 134 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.83284824 |
| 135 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.82624721 |
| 136 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.80891653 |
| 137 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.79704421 |
| 138 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.78984119 |
| 139 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.78212495 |
| 140 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.77365709 |
| 141 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.76561693 |
| 142 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.75852869 |
| 143 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.75302054 |
| 144 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.74935174 |
| 145 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.74900254 |
| 146 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.73567615 |
| 147 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.73184089 |
| 148 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.73026134 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.73112869 |
| 2 | MP0003880_abnormal_central_pattern | 5.20829805 |
| 3 | MP0004270_analgesia | 4.22148732 |
| 4 | * MP0003635_abnormal_synaptic_transmissio | 4.21194220 |
| 5 | MP0001968_abnormal_touch/_nociception | 3.55590840 |
| 6 | * MP0002063_abnormal_learning/memory/cond | 3.44984625 |
| 7 | MP0009745_abnormal_behavioral_response | 3.42838728 |
| 8 | MP0002064_seizures | 3.20713051 |
| 9 | MP0002734_abnormal_mechanical_nocicepti | 2.94505044 |
| 10 | MP0009046_muscle_twitch | 2.94155561 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.90331093 |
| 12 | MP0002736_abnormal_nociception_after | 2.87267009 |
| 13 | MP0009780_abnormal_chondrocyte_physiolo | 2.82181878 |
| 14 | MP0002735_abnormal_chemical_nociception | 2.47221507 |
| 15 | MP0005423_abnormal_somatic_nervous | 2.45098471 |
| 16 | MP0002272_abnormal_nervous_system | 2.45043172 |
| 17 | MP0001486_abnormal_startle_reflex | 2.38654242 |
| 18 | MP0003879_abnormal_hair_cell | 2.24131716 |
| 19 | MP0003123_paternal_imprinting | 2.22788265 |
| 20 | MP0002822_catalepsy | 2.15553105 |
| 21 | MP0001440_abnormal_grooming_behavior | 2.15102345 |
| 22 | MP0002733_abnormal_thermal_nociception | 2.05784615 |
| 23 | MP0001501_abnormal_sleep_pattern | 2.04691733 |
| 24 | MP0002067_abnormal_sensory_capabilities | 2.00889894 |
| 25 | MP0001970_abnormal_pain_threshold | 1.99855983 |
| 26 | MP0000778_abnormal_nervous_system | 1.94402168 |
| 27 | MP0004858_abnormal_nervous_system | 1.91127062 |
| 28 | MP0003787_abnormal_imprinting | 1.88368646 |
| 29 | MP0002184_abnormal_innervation | 1.82443326 |
| 30 | * MP0004811_abnormal_neuron_physiology | 1.82148789 |
| 31 | MP0002557_abnormal_social/conspecific_i | 1.80346746 |
| 32 | MP0005646_abnormal_pituitary_gland | 1.77399410 |
| 33 | MP0008569_lethality_at_weaning | 1.71907019 |
| 34 | MP0003329_amyloid_beta_deposits | 1.69407075 |
| 35 | MP0001984_abnormal_olfaction | 1.69284185 |
| 36 | MP0004924_abnormal_behavior | 1.66431900 |
| 37 | MP0005386_behavior/neurological_phenoty | 1.66431900 |
| 38 | MP0000920_abnormal_myelination | 1.51433613 |
| 39 | MP0004510_myositis | 1.50357013 |
| 40 | MP0002909_abnormal_adrenal_gland | 1.48608726 |
| 41 | MP0000955_abnormal_spinal_cord | 1.47988173 |
| 42 | MP0006276_abnormal_autonomic_nervous | 1.44893877 |
| 43 | MP0003690_abnormal_glial_cell | 1.38413775 |
| 44 | * MP0002882_abnormal_neuron_morphology | 1.38034038 |
| 45 | MP0002066_abnormal_motor_capabilities/c | 1.37948524 |
| 46 | MP0003633_abnormal_nervous_system | 1.36905145 |
| 47 | MP0001502_abnormal_circadian_rhythm | 1.36450462 |
| 48 | MP0005645_abnormal_hypothalamus_physiol | 1.36072072 |
| 49 | MP0001905_abnormal_dopamine_level | 1.23277272 |
| 50 | MP0003122_maternal_imprinting | 1.19072878 |
| 51 | MP0004885_abnormal_endolymph | 1.16973793 |
| 52 | MP0003631_nervous_system_phenotype | 1.12050867 |
| 53 | MP0003172_abnormal_lysosome_physiology | 1.11647452 |
| 54 | MP0001188_hyperpigmentation | 1.11162165 |
| 55 | MP0002152_abnormal_brain_morphology | 1.10574638 |
| 56 | MP0000751_myopathy | 1.09416405 |
| 57 | MP0003283_abnormal_digestive_organ | 1.07115061 |
| 58 | MP0010386_abnormal_urinary_bladder | 1.03676181 |
| 59 | MP0004742_abnormal_vestibular_system | 1.00625524 |
| 60 | MP0002876_abnormal_thyroid_physiology | 1.00617019 |
| 61 | MP0008872_abnormal_physiological_respon | 1.00023991 |
| 62 | MP0001529_abnormal_vocalization | 0.96926884 |
| 63 | MP0002069_abnormal_eating/drinking_beha | 0.94973476 |
| 64 | MP0003183_abnormal_peptide_metabolism | 0.94092062 |
| 65 | MP0005499_abnormal_olfactory_system | 0.93691522 |
| 66 | MP0005394_taste/olfaction_phenotype | 0.93691522 |
| 67 | MP0004142_abnormal_muscle_tone | 0.91178336 |
| 68 | MP0008874_decreased_physiological_sensi | 0.89970618 |
| 69 | MP0000569_abnormal_digit_pigmentation | 0.89840712 |
| 70 | MP0001963_abnormal_hearing_physiology | 0.88593989 |
| 71 | MP0000013_abnormal_adipose_tissue | 0.85562278 |
| 72 | MP0002653_abnormal_ependyma_morphology | 0.85092779 |
| 73 | MP0002229_neurodegeneration | 0.80210725 |
| 74 | MP0002837_dystrophic_cardiac_calcinosis | 0.78975134 |
| 75 | MP0004085_abnormal_heartbeat | 0.78327188 |
| 76 | MP0005623_abnormal_meninges_morphology | 0.75294529 |
| 77 | MP0000631_abnormal_neuroendocrine_gland | 0.74959013 |
| 78 | MP0005535_abnormal_body_temperature | 0.73315146 |
| 79 | MP0001664_abnormal_digestion | 0.72081624 |
| 80 | MP0004145_abnormal_muscle_electrophysio | 0.71346177 |
| 81 | MP0001986_abnormal_taste_sensitivity | 0.69492268 |
| 82 | MP0002638_abnormal_pupillary_reflex | 0.68965395 |
| 83 | MP0005551_abnormal_eye_electrophysiolog | 0.68228161 |
| 84 | MP0002752_abnormal_somatic_nervous | 0.68109981 |
| 85 | MP0004484_altered_response_of | 0.67847908 |
| 86 | MP0000604_amyloidosis | 0.67739415 |
| 87 | MP0001485_abnormal_pinna_reflex | 0.67346084 |
| 88 | MP0001177_atelectasis | 0.66477496 |
| 89 | MP0003121_genomic_imprinting | 0.63767883 |
| 90 | MP0003075_altered_response_to | 0.63624981 |
| 91 | MP0008004_abnormal_stomach_pH | 0.62455756 |
| 92 | MP0008961_abnormal_basal_metabolism | 0.62425567 |
| 93 | MP0008877_abnormal_DNA_methylation | 0.60860031 |
| 94 | MP0003861_abnormal_nervous_system | 0.60476731 |
| 95 | MP0004233_abnormal_muscle_weight | 0.60250515 |
| 96 | MP0001348_abnormal_lacrimal_gland | 0.59820323 |
| 97 | MP0003632_abnormal_nervous_system | 0.59184276 |
| 98 | MP0003634_abnormal_glial_cell | 0.58958598 |
| 99 | MP0003045_fibrosis | 0.58451188 |
| 100 | MP0001943_abnormal_respiration | 0.57129001 |
| 101 | MP0004130_abnormal_muscle_cell | 0.56088270 |
| 102 | MP0001299_abnormal_eye_distance/ | 0.56020385 |
| 103 | MP0010769_abnormal_survival | 0.55583649 |
| 104 | MP0001346_abnormal_lacrimal_gland | 0.55152810 |
| 105 | MP0005171_absent_coat_pigmentation | 0.54830221 |
| 106 | MP0010770_preweaning_lethality | 0.54771389 |
| 107 | MP0002082_postnatal_lethality | 0.54771389 |
| 108 | MP0004215_abnormal_myocardial_fiber | 0.54709339 |
| 109 | MP0002751_abnormal_autonomic_nervous | 0.52808590 |
| 110 | MP0005167_abnormal_blood-brain_barrier | 0.52532737 |
| 111 | MP0010768_mortality/aging | 0.52476055 |
| 112 | MP0004043_abnormal_pH_regulation | 0.52214682 |
| 113 | MP0002090_abnormal_vision | 0.51020336 |
| 114 | MP0005187_abnormal_penis_morphology | 0.50716988 |
| 115 | MP0001765_abnormal_ion_homeostasis | 0.50092860 |
| 116 | MP0005166_decreased_susceptibility_to | 0.49952998 |
| 117 | MP0000639_abnormal_adrenal_gland | 0.49538641 |
| 118 | * MP0003956_abnormal_body_size | 0.49330178 |
| 119 | MP0005409_darkened_coat_color | 0.48768697 |
| 120 | MP0001944_abnormal_pancreas_morphology | 0.47591218 |
| 121 | MP0005448_abnormal_energy_balance | 0.47514964 |
| 122 | MP0003137_abnormal_impulse_conducting | 0.46930778 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.96054953 |
| 2 | Myokymia (HP:0002411) | 6.42801655 |
| 3 | Epileptic encephalopathy (HP:0200134) | 6.32076951 |
| 4 | Focal seizures (HP:0007359) | 5.88006359 |
| 5 | Atonic seizures (HP:0010819) | 5.64168537 |
| 6 | Visual hallucinations (HP:0002367) | 5.33601603 |
| 7 | Febrile seizures (HP:0002373) | 4.89135342 |
| 8 | Hyperventilation (HP:0002883) | 4.80777766 |
| 9 | Absence seizures (HP:0002121) | 4.34769023 |
| 10 | Neurofibrillary tangles (HP:0002185) | 4.32647967 |
| 11 | Broad-based gait (HP:0002136) | 4.09283724 |
| 12 | Dialeptic seizures (HP:0011146) | 4.06452352 |
| 13 | Progressive cerebellar ataxia (HP:0002073) | 3.89269846 |
| 14 | Generalized tonic-clonic seizures (HP:0002069) | 3.87479731 |
| 15 | Poor eye contact (HP:0000817) | 3.68046105 |
| 16 | Amblyopia (HP:0000646) | 3.60249990 |
| 17 | Ankle clonus (HP:0011448) | 3.56479841 |
| 18 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.51530139 |
| 19 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.46029749 |
| 20 | Gaze-evoked nystagmus (HP:0000640) | 3.37620665 |
| 21 | Neuronal loss in central nervous system (HP:0002529) | 3.30941150 |
| 22 | Cerebral hypomyelination (HP:0006808) | 3.19369702 |
| 23 | Tetraplegia (HP:0002445) | 3.13675575 |
| 24 | Abnormality of the lower motor neuron (HP:0002366) | 3.09583496 |
| 25 | Abnormal social behavior (HP:0012433) | 3.09550243 |
| 26 | Impaired social interactions (HP:0000735) | 3.09550243 |
| 27 | Depression (HP:0000716) | 3.05305883 |
| 28 | Intention tremor (HP:0002080) | 3.03269012 |
| 29 | Abnormal eating behavior (HP:0100738) | 3.02349475 |
| 30 | Excessive salivation (HP:0003781) | 2.98608839 |
| 31 | Drooling (HP:0002307) | 2.98608839 |
| 32 | Apathy (HP:0000741) | 2.91703834 |
| 33 | Truncal ataxia (HP:0002078) | 2.88083515 |
| 34 | Epileptiform EEG discharges (HP:0011182) | 2.87882058 |
| 35 | Action tremor (HP:0002345) | 2.86557418 |
| 36 | Supranuclear gaze palsy (HP:0000605) | 2.83961046 |
| 37 | Dysdiadochokinesis (HP:0002075) | 2.82136954 |
| 38 | Insomnia (HP:0100785) | 2.82010464 |
| 39 | Urinary urgency (HP:0000012) | 2.81918574 |
| 40 | Distal upper limb amyotrophy (HP:0007149) | 2.73875538 |
| 41 | Upper limb amyotrophy (HP:0009129) | 2.73875538 |
| 42 | Impaired smooth pursuit (HP:0007772) | 2.73591807 |
| 43 | Hand muscle atrophy (HP:0009130) | 2.72653551 |
| 44 | Mutism (HP:0002300) | 2.71823684 |
| 45 | Dysmetric saccades (HP:0000641) | 2.71684666 |
| 46 | Protruding tongue (HP:0010808) | 2.69164743 |
| 47 | Genetic anticipation (HP:0003743) | 2.66332454 |
| 48 | Diminished motivation (HP:0000745) | 2.64774442 |
| 49 | Insidious onset (HP:0003587) | 2.63857136 |
| 50 | Termporal pattern (HP:0011008) | 2.63857136 |
| 51 | Papilledema (HP:0001085) | 2.61672262 |
| 52 | EEG with generalized epileptiform discharges (HP:0011198) | 2.59828871 |
| 53 | Impaired vibratory sensation (HP:0002495) | 2.58875979 |
| 54 | Inability to walk (HP:0002540) | 2.58755357 |
| 55 | Anxiety (HP:0000739) | 2.58462387 |
| 56 | Stereotypic behavior (HP:0000733) | 2.57263865 |
| 57 | Fetal akinesia sequence (HP:0001989) | 2.56531042 |
| 58 | Dysmetria (HP:0001310) | 2.55744332 |
| 59 | Spastic gait (HP:0002064) | 2.55396554 |
| 60 | Postural instability (HP:0002172) | 2.50117560 |
| 61 | Pheochromocytoma (HP:0002666) | 2.47725130 |
| 62 | Torticollis (HP:0000473) | 2.46974222 |
| 63 | Hypsarrhythmia (HP:0002521) | 2.46806634 |
| 64 | Polyphagia (HP:0002591) | 2.46373904 |
| 65 | Absent speech (HP:0001344) | 2.45682686 |
| 66 | Abnormality of the corticospinal tract (HP:0002492) | 2.43509811 |
| 67 | Bradykinesia (HP:0002067) | 2.38828476 |
| 68 | Rigidity (HP:0002063) | 2.38771077 |
| 69 | Focal dystonia (HP:0004373) | 2.34232867 |
| 70 | Lower limb muscle weakness (HP:0007340) | 2.32894223 |
| 71 | Hyperthyroidism (HP:0000836) | 2.31879190 |
| 72 | Peripheral hypomyelination (HP:0007182) | 2.27961359 |
| 73 | Gait imbalance (HP:0002141) | 2.24539492 |
| 74 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.24453300 |
| 75 | Limb dystonia (HP:0002451) | 2.24087883 |
| 76 | Neuroendocrine neoplasm (HP:0100634) | 2.17830453 |
| 77 | Diplopia (HP:0000651) | 2.16920795 |
| 78 | Abnormality of binocular vision (HP:0011514) | 2.16920795 |
| 79 | Delusions (HP:0000746) | 2.15623501 |
| 80 | Hemiparesis (HP:0001269) | 2.13488080 |
| 81 | Progressive inability to walk (HP:0002505) | 2.12128251 |
| 82 | Spastic tetraparesis (HP:0001285) | 2.12126611 |
| 83 | Status epilepticus (HP:0002133) | 2.11740126 |
| 84 | Blue irides (HP:0000635) | 2.09857717 |
| 85 | Abnormal hair whorl (HP:0010721) | 2.07557662 |
| 86 | Craniofacial dystonia (HP:0012179) | 2.05754570 |
| 87 | Hypoventilation (HP:0002791) | 2.05172497 |
| 88 | Rapidly progressive (HP:0003678) | 2.04184135 |
| 89 | Cerebral inclusion bodies (HP:0100314) | 2.03917337 |
| 90 | Generalized myoclonic seizures (HP:0002123) | 2.03714650 |
| 91 | Abnormality of salivation (HP:0100755) | 2.03706632 |
| 92 | Specific learning disability (HP:0001328) | 2.03238417 |
| 93 | Amyotrophic lateral sclerosis (HP:0007354) | 2.02480632 |
| 94 | Incomplete penetrance (HP:0003829) | 2.01238147 |
| 95 | Failure to thrive in infancy (HP:0001531) | 2.00297229 |
| 96 | Choreoathetosis (HP:0001266) | 1.93873320 |
| 97 | Scanning speech (HP:0002168) | 1.93824140 |
| 98 | Obstructive sleep apnea (HP:0002870) | 1.93004117 |
| 99 | CNS hypomyelination (HP:0003429) | 1.91391849 |
| 100 | Akinesia (HP:0002304) | 1.90310741 |
| 101 | Gait ataxia (HP:0002066) | 1.87281997 |
| 102 | Agitation (HP:0000713) | 1.86999201 |
| 103 | Spinal canal stenosis (HP:0003416) | 1.86454287 |
| 104 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.85789690 |
| 105 | Lower limb amyotrophy (HP:0007210) | 1.84711731 |
| 106 | Resting tremor (HP:0002322) | 1.82768170 |
| 107 | Sleep apnea (HP:0010535) | 1.82629665 |
| 108 | Megalencephaly (HP:0001355) | 1.82081004 |
| 109 | Hemiplegia (HP:0002301) | 1.81470668 |
| 110 | Dementia (HP:0000726) | 1.81185824 |
| 111 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.81017428 |
| 112 | Inappropriate behavior (HP:0000719) | 1.79625413 |
| 113 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.79427752 |
| 114 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.79427752 |
| 115 | Increased circulating renin level (HP:0000848) | 1.77633941 |
| 116 | Diminished movement (HP:0002374) | 1.77295976 |
| 117 | Annular pancreas (HP:0001734) | 1.77076125 |
| 118 | Ventricular fibrillation (HP:0001663) | 1.76157946 |
| 119 | Abnormality of pain sensation (HP:0010832) | 1.75939355 |
| 120 | Impaired pain sensation (HP:0007328) | 1.75939355 |
| 121 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.75503505 |
| 122 | Hypoglycemic seizures (HP:0002173) | 1.74919657 |
| 123 | Intellectual disability, severe (HP:0010864) | 1.73291835 |
| 124 | Congenital primary aphakia (HP:0007707) | 1.73151096 |
| 125 | Growth hormone excess (HP:0000845) | 1.72439028 |
| 126 | Upper limb muscle weakness (HP:0003484) | 1.72430740 |
| 127 | Clonus (HP:0002169) | 1.72247662 |
| 128 | Pointed chin (HP:0000307) | 1.70052484 |
| 129 | Bundle branch block (HP:0011710) | 1.69821966 |
| 130 | Distal sensory impairment (HP:0002936) | 1.66852694 |
| 131 | Abnormality of saccadic eye movements (HP:0000570) | 1.66442809 |
| 132 | Distal lower limb amyotrophy (HP:0008944) | 1.65734106 |
| 133 | Nuclear cataract (HP:0100018) | 1.63780491 |
| 134 | Hyperacusis (HP:0010780) | 1.63674184 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 5.05681104 |
| 2 | EPHA4 | 4.37030415 |
| 3 | NTRK3 | 3.51121156 |
| 4 | MAP3K9 | 3.48679269 |
| 5 | MARK1 | 3.18761950 |
| 6 | MAP3K4 | 3.02790835 |
| 7 | CDK19 | 2.93971694 |
| 8 | MAP2K7 | 2.81005391 |
| 9 | MAP3K12 | 2.51780804 |
| 10 | MINK1 | 2.41095797 |
| 11 | CCNB1 | 2.31985186 |
| 12 | PLK2 | 2.30079479 |
| 13 | PAK6 | 2.11324377 |
| 14 | PRPF4B | 1.96692911 |
| 15 | * DAPK2 | 1.90997873 |
| 16 | MAP2K4 | 1.83330258 |
| 17 | TESK1 | 1.73475344 |
| 18 | CAMKK1 | 1.72488577 |
| 19 | NTRK2 | 1.67442521 |
| 20 | KSR2 | 1.60780124 |
| 21 | GRK5 | 1.60359955 |
| 22 | MAPK13 | 1.59754979 |
| 23 | LIMK1 | 1.59410198 |
| 24 | * DAPK1 | 1.58544039 |
| 25 | AKT3 | 1.57346109 |
| 26 | PRKD3 | 1.51871678 |
| 27 | KSR1 | 1.49048749 |
| 28 | CDK5 | 1.48188537 |
| 29 | NTRK1 | 1.41628274 |
| 30 | OXSR1 | 1.38692086 |
| 31 | CAMKK2 | 1.25183533 |
| 32 | PRKCG | 1.20962437 |
| 33 | ARAF | 1.20336333 |
| 34 | RIPK4 | 1.19536782 |
| 35 | SIK2 | 1.08578584 |
| 36 | RIPK1 | 1.07372423 |
| 37 | MAP3K11 | 1.06049905 |
| 38 | TAOK1 | 1.04008323 |
| 39 | CDK18 | 1.03311061 |
| 40 | SGK223 | 1.01937027 |
| 41 | SGK494 | 1.01937027 |
| 42 | UHMK1 | 0.99591606 |
| 43 | TYRO3 | 0.99203185 |
| 44 | CDK15 | 0.98663927 |
| 45 | PTK2B | 0.97641266 |
| 46 | CDK14 | 0.93781141 |
| 47 | MAP3K2 | 0.91020334 |
| 48 | SGK2 | 0.88667702 |
| 49 | CAMK2A | 0.88289869 |
| 50 | CDK11A | 0.87259700 |
| 51 | PNCK | 0.85386603 |
| 52 | LATS2 | 0.85109633 |
| 53 | TNIK | 0.84108964 |
| 54 | NEK6 | 0.82569878 |
| 55 | STK11 | 0.82564693 |
| 56 | PINK1 | 0.81511913 |
| 57 | SIK3 | 0.80777110 |
| 58 | CAMK1 | 0.80604347 |
| 59 | PHKG1 | 0.79186649 |
| 60 | PHKG2 | 0.79186649 |
| 61 | STK38 | 0.77300195 |
| 62 | BRAF | 0.72565302 |
| 63 | PTK2 | 0.70175724 |
| 64 | CAMK2B | 0.69679029 |
| 65 | SGK3 | 0.68398128 |
| 66 | CSNK1G2 | 0.66881113 |
| 67 | NEK1 | 0.66232968 |
| 68 | MAP2K6 | 0.65615722 |
| 69 | FES | 0.64607143 |
| 70 | RAF1 | 0.62309531 |
| 71 | PRKCH | 0.62256613 |
| 72 | RET | 0.61740826 |
| 73 | DYRK1A | 0.61630150 |
| 74 | BMPR2 | 0.61597030 |
| 75 | MAPK12 | 0.59658228 |
| 76 | PAK3 | 0.58504025 |
| 77 | PKN1 | 0.58419253 |
| 78 | SGK1 | 0.56764874 |
| 79 | BMX | 0.56348936 |
| 80 | MARK2 | 0.56213405 |
| 81 | PDK3 | 0.55087892 |
| 82 | PDK4 | 0.55087892 |
| 83 | PDK1 | 0.54380172 |
| 84 | TSSK6 | 0.53165250 |
| 85 | CAMK4 | 0.52722822 |
| 86 | IRAK2 | 0.51506537 |
| 87 | ERBB3 | 0.50435510 |
| 88 | MAP3K13 | 0.50056307 |
| 89 | PDPK1 | 0.49701337 |
| 90 | IRAK3 | 0.49416194 |
| 91 | PRKCE | 0.48726131 |
| 92 | MAP3K6 | 0.46993388 |
| 93 | ALK | 0.46659374 |
| 94 | MOS | 0.45926593 |
| 95 | NME1 | 0.45793018 |
| 96 | EPHA2 | 0.45238889 |
| 97 | PRKG2 | 0.45195009 |
| 98 | MAPK7 | 0.44200543 |
| 99 | ADRBK1 | 0.43288176 |
| 100 | ROCK2 | 0.42832561 |
| 101 | CAMK1G | 0.42602304 |
| 102 | MAP2K1 | 0.41728807 |
| 103 | PRKCZ | 0.40576069 |
| 104 | RPS6KA2 | 0.39831176 |
| 105 | FGR | 0.38662043 |
| 106 | MST1R | 0.37812105 |
| 107 | BRSK1 | 0.35931607 |
| 108 | RPS6KA3 | 0.35477254 |
| 109 | ROCK1 | 0.35154272 |
| 110 | BCR | 0.34062915 |
| 111 | PRKCA | 0.33621683 |
| 112 | PRKCI | 0.33078315 |
| 113 | FER | 0.32795234 |
| 114 | TAOK2 | 0.32245536 |
| 115 | FYN | 0.31533804 |
| 116 | MAP3K1 | 0.29979572 |
| 117 | PAK1 | 0.29495684 |
| 118 | LMTK2 | 0.28790205 |
| 119 | TNK2 | 0.26217271 |
| 120 | MAPK10 | 0.24288071 |
| 121 | CAMK2D | 0.24082799 |
| 122 | DYRK2 | 0.24067212 |
| 123 | CAMK2G | 0.23842276 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Synaptic vesicle cycle_Homo sapiens_hsa04721 | 4.05918466 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.62456454 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 3.17601707 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.73124316 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.71011333 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.68814606 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.53365391 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.47710385 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.46723498 |
| 10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.35992734 |
| 11 | * Amphetamine addiction_Homo sapiens_hsa05031 | 2.35232255 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.20913618 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.07294340 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 2.05798986 |
| 15 | * Insulin secretion_Homo sapiens_hsa04911 | 2.00544921 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.85259964 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.84273785 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.81348105 |
| 19 | Taste transduction_Homo sapiens_hsa04742 | 1.71204234 |
| 20 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.70810005 |
| 21 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.68769669 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.65112572 |
| 23 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.61973158 |
| 24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.61080773 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.58153998 |
| 26 | Long-term depression_Homo sapiens_hsa04730 | 1.56816071 |
| 27 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.55026475 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.47830301 |
| 29 | Cocaine addiction_Homo sapiens_hsa05030 | 1.44639949 |
| 30 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.39647440 |
| 31 | Gap junction_Homo sapiens_hsa04540 | 1.35467254 |
| 32 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.35439512 |
| 33 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.23656439 |
| 34 | Glioma_Homo sapiens_hsa05214 | 1.23563758 |
| 35 | Axon guidance_Homo sapiens_hsa04360 | 1.23521391 |
| 36 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.23382158 |
| 37 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.18907004 |
| 38 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.16158730 |
| 39 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.12491413 |
| 40 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.12075811 |
| 41 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.09826109 |
| 42 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.08461537 |
| 43 | Melanogenesis_Homo sapiens_hsa04916 | 1.02852953 |
| 44 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.98881793 |
| 45 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.94254035 |
| 46 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.92728677 |
| 47 | Phototransduction_Homo sapiens_hsa04744 | 0.89663064 |
| 48 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.85021028 |
| 49 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.76418297 |
| 50 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.75507081 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.72913103 |
| 52 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.72521046 |
| 53 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71758145 |
| 54 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.70910820 |
| 55 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66917458 |
| 56 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.64749616 |
| 57 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.64305868 |
| 58 | Circadian rhythm_Homo sapiens_hsa04710 | 0.63877456 |
| 59 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.63860300 |
| 60 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.63599987 |
| 61 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.63096999 |
| 62 | Bile secretion_Homo sapiens_hsa04976 | 0.62558246 |
| 63 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.62000708 |
| 64 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60240918 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58637680 |
| 66 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.57998732 |
| 67 | Endometrial cancer_Homo sapiens_hsa05213 | 0.56301666 |
| 68 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55331658 |
| 69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54361882 |
| 70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.54228985 |
| 71 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53083678 |
| 72 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52683832 |
| 73 | Alcoholism_Homo sapiens_hsa05034 | 0.52088763 |
| 74 | Endocytosis_Homo sapiens_hsa04144 | 0.51420219 |
| 75 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.51233308 |
| 76 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.51199166 |
| 77 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50085216 |
| 78 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.48066501 |
| 79 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.47762345 |
| 80 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47253950 |
| 81 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45598019 |
| 82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45280383 |
| 83 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.44705729 |
| 84 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44260127 |
| 85 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43810065 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42420193 |
| 87 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42045221 |
| 88 | Colorectal cancer_Homo sapiens_hsa05210 | 0.42016254 |
| 89 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.41561543 |
| 90 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.40926229 |
| 91 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40217712 |
| 92 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.39094475 |
| 93 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.38717659 |
| 94 | Prion diseases_Homo sapiens_hsa05020 | 0.38623541 |
| 95 | Phagosome_Homo sapiens_hsa04145 | 0.38065284 |
| 96 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.37997768 |
| 97 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.37982234 |
| 98 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.37880250 |
| 99 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.35787776 |
| 100 | Alzheimers disease_Homo sapiens_hsa05010 | 0.34852071 |
| 101 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.33997363 |
| 102 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.33579915 |
| 103 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.33203644 |
| 104 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.31896446 |
| 105 | Mineral absorption_Homo sapiens_hsa04978 | 0.30131229 |
| 106 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.27950732 |
| 107 | Salmonella infection_Homo sapiens_hsa05132 | 0.27474770 |
| 108 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.26442891 |
| 109 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.26307301 |
| 110 | Tight junction_Homo sapiens_hsa04530 | 0.25550573 |
| 111 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.25341524 |
| 112 | * SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.24817476 |
| 113 | Melanoma_Homo sapiens_hsa05218 | 0.24526194 |
| 114 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.24301608 |
| 115 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.23890445 |
| 116 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.23712161 |
| 117 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.22385470 |

